<DOC>
	<DOC>NCT01059643</DOC>
	<brief_summary>The purpose of the study is to estimate the rate of response for patients with ovarian, non-small cell lung, prostate, colorectal, gastroesophageal, and head and neck cancers who are administered LY2523355.</brief_summary>
	<brief_title>A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Diagnosis of ovarian, nonsmall cell lung, prostate, colorectal, gastroesophageal cancer, or squamous cell cancer of the head and neck Have measurable disease defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 guidelines (except prostate cancer patients) Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1 Are willing to follow study procedures for the duration of the study Are willing to use an approved contraceptive method during treatment and for 3 months after discontinuation of study treatment Have a serious preexisting medical condition that would preclude participation in the study Are pregnant or lactating Have received treatment within 28 days of first dose of LY2523355 with a drug that has not received regulatory approval for any indication Have symptomatic, untreated, or uncontrolled central nervous system (CNS) metastases Have a second active primary malignancy or a history of a second malignancy requiring cytotoxic therapy Have QTc interval greater than 470 msec or intraventricular conduction delay (IVCD) with QRS greater than 120 msec on screening electrocardiogram (ECG) Have active symptomatic fungal, bacterial, and/or known viral infection including active human immunodeficiency virus (HIV) or viral (A, B, C) hepatitis Patients with pneumonia, evidence of obstructive pneumonitis, other respiratory infections, or infection from other sources are to be excluded</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>